Lesion Site and Neglect Anosognosia in Patients With Left Hemispatial Neglect

Sponsor
Gazi University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05654350
Collaborator
(none)
100
1
1.5
67.6

Study Details

Study Description

Brief Summary

The goal of this retrospective is to investigate the relationship between lesion site and neglect anosognosia in subacute or chronic right hemispheric stroke patients with left hemispatial neglect. The main questions it aims to answer are:

  • Was any lesion site related to a higher neglect anosognosia rate?

  • Did any lesion site related to a more severe neglect anosognosia? Participants will be divided into two groups regarding the presence of anosognosia for spatial neglect.

Researchers will compare patients with and without anosognosia to see if any lesion site resulted in a higher anosognosia rate and more severe unawareness of neglect symptoms in daily life.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Babinski first defined anosognosia in 1914 as being unaware of paralysis in patients with right hemisphere stroke. Today, this term is used for the unawareness of various neurological and cognitive diseases or disabilities. One of these, anosognosia for hemispatial neglect, is an interesting phenomenon and has not been explored as thoroughly as hemiplegia anosognosia. Lesions of the right superior and inferior temporal gyrus, temporoparietal junction, and insula have been blamed for hemiplegia anosognosia. However, the neural correlates of neglect anosognosia are yet to be elucidated. Therefore, in this study, the investigators aim to investigate the relationship between lesion site and neglect anosognosia in subacute or chronic right hemispheric stroke patients with left hemispatial neglect.

    In this retrospective study, the investigators will screen the medical records of our inpatient cognitive rehabilitation unit from 2011 to 2021. Patients diagnosed with left hemispatial neglect using Catherine Bergego Scale (CBS), line bisection, star cancellation, figure and shape copying, or representational drawing tests will be included in the study. Demographic and clinical data such as age, gender, weeks after stroke, stroke type (ischemic or hemorrhagic), lesion site, Brunnstrom stages, mini-mental status examination score and severities of neglect and neglect anosognosia will be noted.

    Both neglect and neglect anosognosia severities will be determined using CBS. The underestimation of spatial deficits in daily living detected by parallel CBS testing will be considered as neglect anosognosia. The neglect anosognosia score will be calculated by subtracting the patient's self-assessment score from the evaluator-assigned CBS score. A difference of at least one point will be considered the presence of anosognosia. Patients will be divided into two groups with and without anosognosia according to the CBS-anosognosia score. Demographic and clinical features of patients with and without anosognosia will be compared. The correlation between neglect and neglect anosognosia scores will be examined.

    The lesion site will be described by regions of interest (ROI) involvement using a semi-quantitative analyse. The association between anosognosia presence and involvement of the ROI will be analysed using the odds ratio with %95 confidence intervals. Neglect and anosognosia severities will also be compared between involvement and sparing of each ROI. Mini-mental state examination scores will be compared between the groups with and without anosognosia to address mental status, which may be a confounding factor in the evaluation of anosognosia.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    The Relationship Between Lesion Site And Neglect Anosognosia in Right Hemispheric Stroke Patients With Left Hemispatial Neglect
    Actual Study Start Date :
    Dec 16, 2022
    Anticipated Primary Completion Date :
    Jan 15, 2023
    Anticipated Study Completion Date :
    Jan 30, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with neglect anosognosia

    Subacute or chronic right hemispheric stroke patients with left hemispatial neglect and neglect anosognosia.

    Patients without neglect anosognosia

    Subacute or chronic right hemispheric stroke patients with left hemispatial neglect but no neglect anosognosia.

    Outcome Measures

    Primary Outcome Measures

    1. Neglect Score on Catherine Bergego Scale (CBS) [Within the first week of admission to the inpatient rehabilitation clinic]

      CBS-neglect score, which was assigned by an experienced rehabilitation nurse, will be obtained. CBS is a 10-item questionnaire based on direct observation of the patient's activities of daily living such as grooming, dressing, eating, cleaning mouth after a meal, gaze orientation, left limb knowledge, auditory attention, colliding when moving, spatial orientation and, finding belongings. Each item is scored on a 4-point scale ranging from 0 (no ignore) to 3 (severe ignore). The total score ranges from 0 to 30. Higher scores represent more severe spatial neglect behaviour.

    2. Neglect Anosognosia Score on Catherine Bergego Scale (CBS) [Within the first week of admission to the inpatient rehabilitation clinic]

      CBS is a parallel test in which patients can evaluate themselves while an external observer evaluates the patient. The CBS-neglect anosognosia score is calculated by subtracting the patient's self-assessment score from the score given by the external observer for each CBS item. The anosognosia score ranges from 0 to 3 for each item and 0 to 30 in total. Higher scores represent more severe neglect anosognosia.

    3. Lesion site-cortical involvement [Within the first week of admission to the inpatient rehabilitation clinic]

      A semi-quantitative lesion analysis will be conducted on brain magnetic resonance or computed tomography imaging records. Lesions will be scored as 1 or 0, respectively, as those with and without cortical involvement. The frequency of lesions with cortical involvement will be determined.

    4. Lesion site-regions of interest [Within the first week of admission to the inpatient rehabilitation clinic]

      A semi-quantitative lesion analysis will be conducted on brain magnetic resonance or computed tomography imaging records. Lesions will be scored as 1 and 0, respectively, with and without the involvement of each region of interest (ROI). Seven ROIs have been identified: frontal, parietal, temporal, occipital, insula, basal ganglia, and thalamus. The frequencies will be determined for each ROI involvement. The frequency of lesions involving multiple ROIs will also be noted.

    5. Lesion pervasiveness [Within the first week of admission to the inpatient rehabilitation clinic]

      A semi-quantitative lesion analysis will be conducted on brain magnetic resonance or computed tomography imaging records. The total scores of ROIs involved will define the lesion pervasiveness score. It will range from 0 to 7, with a higher score representing a more pervasive lesion.

    Secondary Outcome Measures

    1. Turkish version of the Mini-Mental State Examination (MMSE) [Within the first week of admission to the inpatient rehabilitation clinic]

      Turkish version of the Mini-Mental State Examination (MMSE) is a scale used to evaluate the cognitive status of individuals. It evaluates verbal responses including attention, orientation and memory; the abilities to follow verbal and written orders, write spontaneous sentences, and copy a complex drawing. The score is the number of items answered correctly, giving a total of 0 to 30 points. A score of 23 or less is the accepted cut-off point for cognitive impairment. The lower score represents a more severe cognitive impairment. The reliability and validity studies of the Turkish version of the MMSE were performed by Güngen et al. in 2002.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Being older than 18 years of age

    • Having a subacute or chronic right hemispheric supratentorial stroke

    • Having left hemispatial neglect

    Exclusion Criteria:
    • Being in the first 2 weeks of the stroke

    • Lesions involving the left hemisphere and/or brainstem and/or cerebellum

    • Having other neurological conditions such as traumatic brain injury, central nervous system neoplasm, neurodegenerative or neuropsychiatric diseases

    • Presence of severe cognitive impairment in the mini-mental state examination scale (<10 points)

    • Lack of brain imaging data

    • Having visual problems and psychiatric disorders hindering neglect and anosognosia evaluation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Gazi University Hospital, Department of Physical Medicine and Rehabilitation Ankara Turkey 06560

    Sponsors and Collaborators

    • Gazi University

    Investigators

    • Principal Investigator: Gülçin Kaymak Karataş, MD, Gazi University Faculty of Medicine
    • Principal Investigator: Levent Karataş, MD, Gazi University Faculty of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Levent Karataş, Principal Investigator, MD, Gazi University
    ClinicalTrials.gov Identifier:
    NCT05654350
    Other Study ID Numbers:
    • Anosognosia and lesion site
    First Posted:
    Dec 16, 2022
    Last Update Posted:
    Dec 21, 2022
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Levent Karataş, Principal Investigator, MD, Gazi University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 21, 2022